Wu N, Wang S, Brazeau A, Chan D, Mussa J, Nakhla M
J Med Internet Res. 2023; 25:e48267.
PMID: 38085568
PMC: 10751631.
DOI: 10.2196/48267.
Pincus S, Kyro A, Maresh G, Peters T, Kempa J, Marcotte T
Toxins (Basel). 2022; 14(12).
PMID: 36548717
PMC: 9786807.
DOI: 10.3390/toxins14120820.
Kempa J, OShea-Stone G, Moss C, Peters T, Marcotte T, Tripet B
Toxins (Basel). 2022; 14(12).
PMID: 36548712
PMC: 9782143.
DOI: 10.3390/toxins14120815.
Panzer J, Caicedo A
Diabetes. 2021; 70(12):2721-2732.
PMID: 34872936
PMC: 8660986.
DOI: 10.2337/dbi20-0048.
Brown J, Reichert S, Valliere Y, McLachlan C, Webster-Bogaert S, Ratzki-Leewing A
Diabetes Spectr. 2021; 34(4):388-393.
PMID: 34866872
PMC: 8603122.
DOI: 10.2337/ds20-0061.
A study to assess the unmet medical needs associated with the use of basal insulin in patients with type 2 diabetes.
Frechtel G, Forti L, Faingold C, Perez Mangui F, Orio S, Issa C
Endocrinol Diabetes Metab. 2021; 4(1):e00164.
PMID: 33532606
PMC: 7831225.
DOI: 10.1002/edm2.164.
Cost-Utility Analysis of Saxagliptin/Dapagliflozin Versus Gliclazide and Insulin Glargine: Economic Implications of the Outcomes of the CVD-Real Studies I and II.
Torre E, Bruno G, Di Matteo S, Martinotti C, Valentino M, Bottaro L
Health Serv Insights. 2020; 13:1178632920929982.
PMID: 32595277
PMC: 7298424.
DOI: 10.1177/1178632920929982.
Economic Evaluation of Dulaglutide vs Traditional Therapies: Implications of the Outcomes of the Rewind Study.
Torre E, Bruno G, Di Matteo S, Martinotti C, Valentino M, Bottaro L
Clinicoecon Outcomes Res. 2020; 12:177-189.
PMID: 32308446
PMC: 7152542.
DOI: 10.2147/CEOR.S240183.
Living With Hypoglycemia: An Exploration of Patients' Emotions: Qualitative Findings From the InHypo-DM Study, Canada.
Brown J, Reichert S, Valliere Y, Webster-Bogaert S, Ratzki-Leewing A, Ryan B
Diabetes Spectr. 2019; 32(3):270-276.
PMID: 31462884
PMC: 6695265.
DOI: 10.2337/ds18-0074.
Neuroprotective effect of insulin-loaded chitosan nanoparticles/PLGA-PEG-PLGA hydrogel on diabetic retinopathy in rats.
Rong X, Ji Y, Zhu X, Yang J, Qian D, Mo X
Int J Nanomedicine. 2018; 14:45-55.
PMID: 30587984
PMC: 6302824.
DOI: 10.2147/IJN.S184574.
Cost-minimization analysis of degludec/liraglutide versus glargine/aspart: economic implications of the DUAL VII study outcomes.
Torre E, Bruno G, Di Matteo S, Martinotti C, Oselin M, Valentino M
Clinicoecon Outcomes Res. 2018; 10:413-421.
PMID: 30100746
PMC: 6067612.
DOI: 10.2147/CEOR.S169045.
Allo- and auto-percutaneous intra-portal pancreatic islet transplantation (PIPIT) for diabetes cure and prevention: the role of imaging and interventional radiology.
Venturini M, Sallemi C, Marra P, Palmisano A, Agostini G, Lanza C
Gland Surg. 2018; 7(2):117-131.
PMID: 29770308
PMC: 5938273.
DOI: 10.21037/gs.2017.11.12.
Acute bout of exercise induced prolonged muscle glucose transporter-4 translocation and delayed counter-regulatory hormone response in type 1 diabetes.
Sato K, Nishijima T, Yokokawa T, Fujita S
PLoS One. 2017; 12(6):e0178505.
PMID: 28570686
PMC: 5453522.
DOI: 10.1371/journal.pone.0178505.
Comparison of Antidiabetic Regimens in Patients with Type 2 Diabetes Uncontrolled by Combination Therapy of Sulfonylurea and Metformin: Results of the MOHAS Disease Registry in Korea.
Choi S, Oh T, Jang H
Diabetes Metab J. 2017; 41(3):170-178.
PMID: 28537056
PMC: 5489497.
DOI: 10.4093/dmj.2017.41.3.170.
Reliability of Trained Dogs to Alert to Hypoglycemia in Patients With Type 1 Diabetes.
Los E, Ramsey K, Guttmann-Bauman I, Ahmann A
J Diabetes Sci Technol. 2016; 11(3):506-512.
PMID: 27573791
PMC: 5505410.
DOI: 10.1177/1932296816666537.
Subconjunctivally Implanted Hydrogels for Sustained Insulin Release to Reduce Retinal Cell Apoptosis in Diabetic Rats.
Imai H, Misra G, Wu L, Janagam D, Gardner T, Lowe T
Invest Ophthalmol Vis Sci. 2015; 56(13):7839-46.
PMID: 26658505
PMC: 4682486.
DOI: 10.1167/iovs.15-16998.
Efficacy and safety of fasiglifam (TAK-875), a G protein-coupled receptor 40 agonist, in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise: a randomized, double-blind, placebo-controlled, phase III trial.
Kaku K, Enya K, Nakaya R, Ohira T, Matsuno R
Diabetes Obes Metab. 2015; 17(7):675-81.
PMID: 25787200
PMC: 4676912.
DOI: 10.1111/dom.12467.
Low within- and between-day variability in exposure to new insulin glargine 300 U/ml.
Becker R, Nowotny I, Teichert L, Bergmann K, Kapitza C
Diabetes Obes Metab. 2014; 17(3):261-7.
PMID: 25425394
PMC: 4674964.
DOI: 10.1111/dom.12416.
Defective glucagon secretion during hypoglycemia after intrahepatic but not nonhepatic islet autotransplantation.
Bellin M, Parazzoli S, Oseid E, Bogachus L, Schuetz C, Patti M
Am J Transplant. 2014; 14(8):1880-6.
PMID: 25039984
PMC: 4440232.
DOI: 10.1111/ajt.12776.
Continuous glucose monitors: use of waveform versus glycemic values in the improvements of glucose control, quality of life, and fear of hypoglycemia.
Walker T, Yucha C
J Diabetes Sci Technol. 2014; 8(3):488-93.
PMID: 24876611
PMC: 4455439.
DOI: 10.1177/1932296814528434.